See every side of every news story
Published loading...Updated

Quetiapine may pip lithium to the post for augmentation in 'treatment resistant depression': results from the LQD study - National Elf Service

Summary by National Elf Service
Kirsten Lawson and Douglas Badenoch review the new randomised controlled trial by Cleare et al, published today in The Lancet Psychiatry, directly comparing the clinical and cost effectiveness of lithium and quetiapine as augmentation treatments for patients with 'treatment resistant depression'. The post Quetiapine may pip lithium to the post for augmentation in ‘treatment resistant depression’: results from the LQD study appeared first on Nati…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

National Elf Service broke the news in on Wednesday, March 19, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.